2020
DOI: 10.1039/d0ra05628f
|View full text |Cite
|
Sign up to set email alerts
|

TLC-spectrodensitometric method for simultaneous determination of dapagliflozin and rosuvastatin in rabbit plasma: stability indicating assay and kinetic studies

Abstract: Mixtures of DAPA and ROSV were separated using ethyl acetate : methanol (5 : 0.1 v/v) as mobile phase and applied in plasma and urine samples in addition to stability indicating and kinetic studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Some high-performance thin-layer chromatography (HPTLC) methods are reported for the assay of NOACs and ROS either alone or in combination with other drugs in bulk & pharmaceutical formulations [, , , , , , , 7,8,9,10,11,12,13,14]. RIV is assayed using HPTLC in human plasma [15] and also HPTLC is used to quantify ROS in rabbit plasma [16]. Most bioanalytical techniques available in the literature to quantify NOACs are based on liquid chromatography in human plasma; using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) [, 17, 18], high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) [, , 19,20,21], high-performance liquid chromatography-mass spectrometry (HPLC-MS) [22] and high-performance liquid chromatography-diode array detector (HPLC-DAD) [23].…”
Section: Introductionmentioning
confidence: 99%
“…Some high-performance thin-layer chromatography (HPTLC) methods are reported for the assay of NOACs and ROS either alone or in combination with other drugs in bulk & pharmaceutical formulations [, , , , , , , 7,8,9,10,11,12,13,14]. RIV is assayed using HPTLC in human plasma [15] and also HPTLC is used to quantify ROS in rabbit plasma [16]. Most bioanalytical techniques available in the literature to quantify NOACs are based on liquid chromatography in human plasma; using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) [, 17, 18], high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) [, , 19,20,21], high-performance liquid chromatography-mass spectrometry (HPLC-MS) [22] and high-performance liquid chromatography-diode array detector (HPLC-DAD) [23].…”
Section: Introductionmentioning
confidence: 99%
“…As a result, they are used in combination therapy with other antidiabetic drugs such as MET (Lajara, 2014). The reported methods for analysis of DAPA and MET in combination include UV spectrophotometry (Bhavyasri & Surekha, 2020; Jani et al, 2015), RP‐HPLC (Abbas et al, 2020; Khalil et al, 2018; Urooj et al, 2017), LC–UV (Hassib et al, 2019), LC–MS/MS (Dias et al, 2019; Shah et al, 2019), capillary electrophoresis (Maher et al, 2019) and TLC–spectrodensitometric methods for simultaneous analysis of DAPA and MET (Abdelrahman et al, 2020; Nasser et al, 2018). These methods are less sensitive with several mobile phases and are applied only to pharmaceutical formulations.…”
Section: Introductionmentioning
confidence: 99%